Matthias M Schweiger

967 posts

Matthias M Schweiger

Matthias M Schweiger

@mattmschweiger

Product Litigation Lawyer, Partner at Hogan Lovells @HLLifeSciences @HLProductLaw

München, Bayern Katılım Mart 2015
159 Takip Edilen110 Takipçiler
Matthias M Schweiger
Matthias M Schweiger@mattmschweiger·
The U.S. Food and Drug Administration continues to explore the development of a standardized front of package nutrition labeling scheme by conducting consumer research. CVSoci.al/syIiM9vW
English
0
0
0
17
Matthias M Schweiger
Matthias M Schweiger@mattmschweiger·
We are pleased to announce the return of partner, Rafael Ribeiro to our Miami office following an in-house position as Assistant General Counsel with the Global Ethics and Compliance Management team at The Walt Disney Company. CVSoci.al/HViMqFQu
English
0
0
0
39
Matthias M Schweiger
Matthias M Schweiger@mattmschweiger·
For #pharmaceutical companies, the possibility of investment #arbitration is for the most part quite opaque. However, recent case law shows that the chances of success for investors are higher than expected. Partners Andrea Atteritano and Christian Di… CVSoci.al/jf7qWLXc
English
0
0
0
0
Matthias M Schweiger
Matthias M Schweiger@mattmschweiger·
How is your business addressing heightened ESG expectations? We interviewed 600 compliance leaders to get their views. Read our report to find out about the issues they identified, and our insights on how to navigate them. CVSoci.al/u5eYsArh
English
0
0
0
0
Matthias M Schweiger
Matthias M Schweiger@mattmschweiger·
In this article, we analyze how FDA issued a revised draft guidance, “Charging for Investigational Drugs Under an IND: Questions and Answers,” adding information related to the need for submission of a statement by an independent certified public… CVSoci.al/uPI0ZOdq
English
0
0
0
0
Matthias M Schweiger
Matthias M Schweiger@mattmschweiger·
Join us for the next installment of our Consumer Horizons webinars series which will focus on the ever changing and fast paced landscape of online and digital payments. Topics include; Digital currency in China; Buy Now Pay Later; and Cryptocurrency. CVSoci.al/NFGmbcvH
English
0
0
1
0
Matthias M Schweiger
Matthias M Schweiger@mattmschweiger·
An international team advised Covestro AG, one of the world's leading manufacturers of high-quality #plastics and their components, on the sale of its additive #manufacturing business to US-Israeli Stratasys Group. http://ow.​ly/fL9350KAju0
Matthias M Schweiger tweet media
English
0
0
0
0
Matthias M Schweiger
Matthias M Schweiger@mattmschweiger·
A recent amendment to the consumer code has changed the systematic framework of compliance requirements for consumer goods. The new rules, effective from 1 January 2022, will impact not only operators selling consumer goods but also manufacturers. CVSoci.al/RQUge1fh
English
0
0
0
0
Matthias M Schweiger
Matthias M Schweiger@mattmschweiger·
Our Hamburg, Berlin and Munich lawyers discuss the new sustainability requirements under the German Packaging Act. Check out what's new below: CVSoci.al/pZucfa2k
English
0
0
0
0
Matthias M Schweiger
Matthias M Schweiger@mattmschweiger·
From June 26th, 2022, the “Italian Sunshine Act” entered into force. This is a piece of legislation aimed at preventing corruption and fostering transparency in the #health sector by imposing disclosure obligations on companies in the #pharmaceuticalCVSoci.al/O7HIklML
English
0
0
3
0
Matthias M Schweiger
Matthias M Schweiger@mattmschweiger·
Allison Holt Ryan, Adam Cooke, Lance Murashige, Joe Cavanaugh, and Courtney Helt discuss how a jury finds defendant not negligent for response to data breach. Read more: CVSoci.al/6cqpzu0y
English
0
0
0
0
Matthias M Schweiger
Matthias M Schweiger@mattmschweiger·
Join the Hogan Lovells Food & Beverage and #ClassAction teams on Tuesday May 17, 2022 for the next webinar in our A Seat at the Table series. Our panelists will lead a discussion on key issues in food class action litigation, including the meaning of the… CVSoci.al/uM-Qcpve
English
0
0
0
0
Matthias M Schweiger
Matthias M Schweiger@mattmschweiger·
On April 14, the U.S. Food and Drug Administration (FDA) released a new draft guidance to industry for increasing racial and ethnic diversity in clinical trials, titled "Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial… CVSoci.al/be8hE8bO
English
0
0
0
0
Matthias M Schweiger
Matthias M Schweiger@mattmschweiger·
Register now for The MedTech Forum, where partner Fabien Roy will lead the “Ask The Expert” session on best practices for dealing with complex situations during #MDR conformity assessment procedures. #MTF2022 CVSoci.al/TN3XxVhD
English
0
0
0
0
Matthias M Schweiger
Matthias M Schweiger@mattmschweiger·
Want to know more about artificial intelligence/machine learning based software as a medical device? Join partner Arne Thiermann’s “Ask The Expert” session at The MedTech Forum, which will also cover implications of the coming EU Artificial Intelligence… CVSoci.al/UanKZaln
English
0
0
0
0